Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
NCT04734379
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Progressive Supranuclear Palsy
Corticobasal Syndrome
Interventions
DRUG:
Fasudil
Sponsor
Woolsey Pharmaceuticals